We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Contact-Free System Monitors Hospital Patients

By HospiMedica staff writers
Posted on 03 Dec 2007
A contact-free heart and respiration monitor enables medical establishments to bridge the critical time gap between sudden patient deterioration and clinician intervention.

The EverOn heart and respiration monitor is composed of a unique sensing unit (a single plate with multi-technology mechanical sensors) and a control unit that integrates signal intake and sampling, signal processing and display, and various alert outputs. More...
Once placed beneath a bed mattress, or between the mattress and pad, the sensing unit immediately self-activates whenever the patient is in bed. The data that are continuously filtered, sampled, and analyzed can be stored, and if desired can be presented later on for off-line clinician analysis.

The monitor features a real-time connection to the caregiver's call system and triggers an audible alarm, enabling a proactive response that may potentially avert medical crises before they materialize. EverOn also promotes optimal use of the available medical resources and manpower.

The monitor is designed for any indoor environment--including hospital, clinics, and homes--and performs equally well in chairs and wheelchairs. The sensors are disposable to maintain a high standard of hygiene. Potential applications which are currently in research include monitoring patients in general hospital wards and/or acute care settings, evaluating changes in respiratory or heart rate patterns, and detecting early-warning signs of asthma attacks, chronic obstructive pulmonary disease (COPD), and chronic heart failure (CHF) deteriorations. The EverOn monitor was developed by EarlySense (Ramat Gan, Israel), and has been approved by the [U.S.] Food and Drug Administration (FDA).

"Hospitals and other healthcare providers are facing a growing challenge in treating older and sicker patients. Such providers are looking for technological solutions that allow them to increase the quality of care and improve patient safety without adding to already stretched budgets and manpower,” said Avner Halperin, EarlySense CEO. "We have addressed this need with a smart monitoring solution that facilitates the improvement of patient safety and nursing efficiencies.”


Related Links:
EarlySense

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Radiation Safety Barrier
RayShield Intensi-Barrier
Mammography System (Analog)
MAM VENUS
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.